The novel PI3 kinase inhibitor, BAY 80-6946, impairs melanoma growthin vivoandin vitro-Reference-Cited by-同舟云学术

The novel PI3 kinase inhibitor, BAY 80-6946, impairs melanoma growthin vivoandin vitro

Published:2014-08 Issue:8 Volume:23 Page:579-584
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Schneider Philine¹,Schön Margarete¹,Pletz Nadin¹,Seitz Cornelia S.¹,Liu Ningshu²,Ziegelbauer Karl²,Zachmann Karolin¹,Emmert Steffen¹,Schön Michael P.¹

Affiliation:

1. Department of Dermatology, Venereology and Allergology; University Medical Center; Georg August University; Göttingen Germany

2. BayerHealthCare; Global Drug Discovery; Wuppertal Germany

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/exd.12470/fullpdf

Reference44 articles.

1. Resistance to RAF Inhibitors Revisited

2. Tumor adaptation and resistance to RAF inhibitors

3. Nuclear factor-κB inhibitors as sensitizers to anticancer drugs

4. Drug-resistance in human melanoma

5. Apoptosis and melanoma chemoresistance

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance;Cells;2024-01-26

2. Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma;Pharmaceutics;2023-08-14

3. Co-administration of MDR1 and BCRP or EGFR/PI3K inhibitors overcomes lenvatinib resistance in hepatocellular carcinoma;Frontiers in Oncology;2022-09-08

4. Icariin inhibits oral squamous cell carcinoma cell proliferation and induces apoptosis via inhibiting the NF‑κB and PI3K/AKT pathways;Experimental and Therapeutic Medicine;2021-07-01

5. Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer;Cell Death & Disease;2020-11